Solid Biosciences (SLDB) Change in Receivables (2021 - 2022)
Solid Biosciences' (SLDB) quarterly Change in Receivables came in at -$14000.0 in Q2 2022, down 333.33% year-on-year from $6000.0 in Q2 2021, and up 85.42% quarter-over-quarter from -$96000.0 in Q1 2022.
Solid Biosciences (SLDB) Change in Receivables (2021 - 2022) Analysis & Trends
Solid Biosciences has disclosed Change in Receivables across 2 years of filings, most recently posting -$14000.0 for Q2 2022.
- Change in Receivables for Q2 2022 came in at -$14000.0, down 333.33% year-over-year; the trailing twelve-month figure through Dec 2022 was -$110000.0 (down 200.0% YoY), and the FY2022 annual result was -$110000.0, down 200.0% from the prior year.
- Change in Receivables came in at -$14000.0 for Q2 2022 at Solid Biosciences, up from -$96000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $308000.0 in Q3 2021 to a low of -$484000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -4.08 Mn |
| 10 | Solid Biosciences | 789.54 Mn | 408.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -14,000.00 |
| Jun 30, 2022 | -14,000.00 |
| Mar 31, 2022 | -96,000.00 |
| Mar 31, 2022 | -96,000.00 |
| Dec 31, 2021 | -484,000.00 |
| Dec 31, 2021 | -484,000.00 |
| Sep 30, 2021 | 308,000.00 |
| Sep 30, 2021 | 308,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 280,000.00 |
| Mar 31, 2021 | 280,000.00 |